Aortic Stenosis
Cardiovascular·MeSH: Aortic Valve Stenosis
Prevalence
30.0 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| pelacarsen | Novartis AG (NVS) |
Frequently asked questions
How many drugs are in development for Aortic Stenosis?
BioSniper tracks 1 drug in development for Aortic Stenosis across 1 company.
How many clinical trials target Aortic Stenosis?
There are 3 clinical trials targeting Aortic Stenosis tracked by BioSniper.
What is the prevalence of Aortic Stenosis?
The estimated prevalence of Aortic Stenosis is approximately 30.0 per 100,000 population.
Deep-dive into Aortic Stenosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis